Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

NCT03802617 is registered in ClinicalTrials.gov with Kissei Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT03802617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03802617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.
Lead sponsor
Kissei Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2019
Completion date
October 22, 2019
Enrollment
247 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uremic pruritus